Krishna Chatterjee

26.6k total citations · 2 hit papers
204 papers, 14.8k citations indexed

About

Krishna Chatterjee is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Krishna Chatterjee has authored 204 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Endocrinology, Diabetes and Metabolism, 82 papers in Molecular Biology and 51 papers in Genetics. Recurrent topics in Krishna Chatterjee's work include Thyroid Disorders and Treatments (95 papers), Growth Hormone and Insulin-like Growth Factors (57 papers) and Peroxisome Proliferator-Activated Receptors (33 papers). Krishna Chatterjee is often cited by papers focused on Thyroid Disorders and Treatments (95 papers), Growth Hormone and Insulin-like Growth Factors (57 papers) and Peroxisome Proliferator-Activated Receptors (33 papers). Krishna Chatterjee collaborates with scholars based in United Kingdom, United States and Italy. Krishna Chatterjee's co-authors include Stephen O’Rahilly, Mark Gurnell, John W. R. Schwabe, Maura Agostini, Mitchell A. Lazar, Matthew Adams, John M. Wentworth, P. Beck‐Peccoz, Trevor N. Collingwood and David B. Savage and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Krishna Chatterjee

200 papers receiving 14.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension

1999 1.1k citations Mark Gurnell, Maura Agostini et al. profile →
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors

2006 813 citations Krishna Chatterjee, Mitchell A. Lazar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Krishna Chatterjee United Kingdom	62	6.9k	5.8k	2.9k	2.8k	2.0k	204	14.8k
Curt D. Sigmund United States	67	6.7k 1.0×	3.6k 0.6×	2.8k 1.0×	1.4k 0.5×	974 0.5×	315	15.3k
Paul M. Yen United States	52	4.7k 0.7×	4.9k 0.8×	1.3k 0.5×	2.7k 0.9×	2.2k 1.1×	180	10.8k
Takao Saruta Japan	64	3.8k 0.5×	4.8k 0.8×	3.0k 1.0×	1.4k 0.5×	1.8k 0.9×	531	15.5k
Akiyoshi Fukamizu Japan	75	10.8k 1.6×	3.1k 0.5×	2.3k 0.8×	1.8k 0.6×	1.6k 0.8×	365	20.9k
Matthew D. Breyer United States	70	6.6k 1.0×	2.8k 0.5×	2.6k 0.9×	1.9k 0.7×	773 0.4×	204	16.0k
Hans‐Georg Joost Germany	63	6.6k 1.0×	2.5k 0.4×	3.8k 1.3×	1.8k 0.6×	2.0k 1.0×	277	13.6k
Terry G. Unterman United States	62	7.3k 1.1×	2.6k 0.4×	2.5k 0.8×	1.2k 0.4×	1.0k 0.5×	157	12.6k
John W. Harney United States	59	4.7k 0.7×	4.9k 0.8×	1.8k 0.6×	1.6k 0.6×	961 0.5×	115	11.4k
Simeon I. Taylor United States	65	8.5k 1.2×	4.1k 0.7×	3.3k 1.1×	2.4k 0.9×	2.0k 1.0×	194	14.7k
Yasuo Terauchi Japan	60	7.8k 1.1×	5.4k 0.9×	3.9k 1.3×	1.8k 0.6×	4.3k 2.1×	377	17.3k

Countries citing papers authored by Krishna Chatterjee

Since Specialization

Citations

This map shows the geographic impact of Krishna Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Chatterjee more than expected).

Fields of papers citing papers by Krishna Chatterjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishna Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Chatterjee. The network helps show where Krishna Chatterjee may publish in the future.

Co-authorship network of co-authors of Krishna Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Krishna Chatterjee. A scholar is included among the top collaborators of Krishna Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishna Chatterjee. Krishna Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moran, Carla, Julie Martin‐Grace, Greta Lyons, et al.. (2025). TRIAC Therapy Relieves Hyperthyroid Symptoms, Lowering T4, T3, and Metabolic Rate in Resistance to Thyroid Hormone β. The Journal of Clinical Endocrinology & Metabolism. 111(4). 980–987.

Agostini, Maura, Erik Schoenmakers, Sezer Acar, et al.. (2023). Human resistance to thyroid hormone beta operates via a mechanism requiring receptor binding to DNA. Endocrine Abstracts. 1 indexed citations

Baldeweg, Stephanie E, Kristien Boelaert, Krishna Chatterjee, et al.. (2023). Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement. Clinical Endocrinology. 99(2). 206–216. 16 indexed citations

Schoenmakers, Erik & Krishna Chatterjee. (2020). Human Disorders Affecting the Selenocysteine Incorporation Pathway Cause Systemic Selenoprotein Deficiency. Antioxidants and Redox Signaling. 33(7). 481–497. 25 indexed citations

Krieger, Teresa G., Carla Moran, W. Edward Visser, et al.. (2019). Mutations in thyroid hormone receptor α1 cause premature neurogenesis and progenitor cell depletion in human cortical development. Proceedings of the National Academy of Sciences. 116(45). 22754–22763. 25 indexed citations

Watson, Laura, Michelle Venables, Carlo L. Acerini, et al.. (2019). Quantifying energy expenditure in childhood: utility in managing pediatric metabolic disorders. American Journal of Clinical Nutrition. 110(5). 1186–1191. 3 indexed citations

Groeneweg, Stefan, Yvonne Hilhorst‐Hofstee, Krishna Chatterjee, et al.. (2019). Insight Into Molecular Determinants of T3 vs T4 Recognition From Mutations in Thyroid Hormone Receptor α and β. The Journal of Clinical Endocrinology & Metabolism. 104(8). 3491–3500. 21 indexed citations

Casey, Ruth, Olivier Giger, Ian Seetho, et al.. (2018). Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab. Seminars in Oncology. 45(3). 151–155. 23 indexed citations

Moran, Carla, Maura Agostini, Anne McGowan, et al.. (2017). Contrasting Phenotypes in Resistance to Thyroid Hormone Alpha Correlate with Divergent Properties of Thyroid Hormone Receptor α1 Mutant Proteins. Thyroid. 27(7). 973–982. 39 indexed citations

10.

Gurnell, Mark, David Halsall, & Krishna Chatterjee. (2011). What should be done when thyroid function tests do not make sense?. Clinical Endocrinology. 74(6). 673–678. 56 indexed citations

11.

Halsall, David, et al.. (2010). Metyrapone interference in serum cortisol immunoassay. 21. 1 indexed citations

12.

Savage, David B., Sylvie Dufour, Nadia Schoenmakers, et al.. (2010). Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. Journal of Clinical Investigation. 120(4). 1345–1354. 90 indexed citations

13.

Gurnell, Eleanor, Penelope J. Hunt, Suzanne Curran, et al.. (2007). Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 93(2). 400–409. 142 indexed citations

14.

Chatterjee, Krishna. (2006). PPAR gamma and human metabolic disease. 186 indexed citations

15.

Park, Seongjun, Roderick Clifton‐Bligh, P R Betts, & Krishna Chatterjee. (2004). Congenital hypothyroidism and apparent athyreosis with compound heterozygosity or compensated hypothyroidism with probable hemizygosity for inactivating mutations of the TSH receptor. Clinical Endocrinology. 60(2). 220–227. 35 indexed citations

16.

Kahaly, George J., et al.. (2002). Cardiac Involvement in Thyroid Hormone Resistance. The Journal of Clinical Endocrinology & Metabolism. 87(1). 204–212. 47 indexed citations

17.

Wang, Chenguang, Maofu Fu, Mark D’Amico, et al.. (2001). Inhibition of Cellular Proliferation through IκB Kinase-Independent and Peroxisome Proliferator-Activated Receptor γ-Dependent Repression of Cyclin D1. Molecular and Cellular Biology. 21(9). 3057–3070. 148 indexed citations

18.

Adams, Matthew, Charles H. Matthews, Trevor N. Collingwood, et al.. (1994). Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene.. Journal of Clinical Investigation. 94(2). 506–515. 186 indexed citations

19.

Beck‐Peccoz, P., Krishna Chatterjee, W W Chin, et al.. (1994). Nomenclature of Thyroid Hormone Receptor β Mutations in Resistance to Thyroid Hormone: Consensus Statement from the First Workshop on Thyroid Hormone Resistance, July 10–11th 1993, Cambridge, U.K.. Thyroid. 4(1). 135–137. 2 indexed citations

20.

Collingwood, Trevor N., Mark Sydenham, Martin Pagé, & Krishna Chatterjee. (1991). Functional properties of human thyroid hormone receptor β1 overexpressed using baculovirus. FEBS Letters. 291(2). 315–318. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact